TipRanks
Zealand Pharma (DE:22Z)
XETRA:22Z
Germany Market
22Z
Zealand Pharma
RESEARCH TOOLSreports

Zealand Pharma (22Z) Ratios

18 Followers

Zealand Pharma Ratios

DE:22Z's free cash flow for Q2 2026 was kr1.00. For the 2026 fiscal year, DE:22Z's free cash flow was decreased by kr and operating cash flow was kr0.86. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 13.98 23.57 21.14 6.25 6.73
Quick Ratio
 13.98 23.57 21.11 6.23 6.73
Cash Ratio
 3.02 6.88 1.19 1.58 5.47
Solvency Ratio
 1.58 3.97 -1.18 -1.75 -1.29
Operating Cash Flow Ratio
 -1.31 9.82 -2.31 -1.50 -4.82
Short-Term Operating Cash Flow Coverage
 -60.43 0.00 -58.05 0.00 0.00
Net Current Asset Value
kr 16.93Bkr 14.04Bkr 7.64Bkr 1.39Bkr 592.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.04 0.06 0.29
Debt-to-Equity Ratio
 0.02 0.03 0.05 0.07 0.54
Debt-to-Capital Ratio
 0.02 0.03 0.04 0.07 0.35
Long-Term Debt-to-Capital Ratio
 0.02 0.02 0.03 0.00 0.28
Financial Leverage Ratio
 1.10 1.11 1.10 1.24 1.89
Debt Service Coverage Ratio
 36.67 176.05 -17.78 -22.31 -15.56
Interest Coverage Ratio
 58.46 189.81 -31.11 -19.75 -14.46
Debt to Market Cap
 0.02 <0.01 <0.01 0.00 0.03
Interest Debt Per Share
 6.41 6.29 6.51 2.62 10.82
Net Debt to EBITDA
 -1.38 -0.58 0.09 0.51 0.71
Profitability Margins
Gross Profit Margin
99.22%99.69%87.44%94.41%70.47%
EBIT Margin
55.98%77.66%-1662.99%-198.34%-880.49%
EBITDA Margin
56.76%77.95%-1621.76%-190.08%-850.96%
Operating Profit Margin
50.57%77.66%-2029.33%-166.94%-785.30%
Pretax Profit Margin
61.13%75.98%-1728.23%-206.79%-934.78%
Net Profit Margin
59.00%70.05%-1720.87%-205.30%-928.60%
Continuous Operations Profit Margin
59.00%70.05%-1720.87%-205.30%-928.60%
Net Income Per EBT
96.51%92.20%99.57%99.28%99.34%
EBT Per EBIT
120.90%97.84%85.16%123.88%119.04%
Return on Assets (ROA)
13.86%39.21%-11.35%-35.54%-62.71%
Return on Equity (ROE)
17.54%43.52%-12.52%-44.18%-118.35%
Return on Capital Employed (ROCE)
12.74%45.30%-13.98%-33.75%-60.74%
Return on Invested Capital (ROIC)
12.28%41.71%-13.87%-33.18%-59.69%
Return on Tangible Assets
14.48%39.32%-11.36%-35.76%-62.71%
Earnings Yield
13.81%19.63%-2.27%-3.33%-10.38%
Efficiency Ratios
Receivables Turnover
 1.18 31.92 0.45 2.80 0.76
Payables Turnover
 0.25 0.11 0.04 0.21 0.17
Inventory Turnover
 0.00 0.00 0.74 2.42 23.88
Fixed Asset Turnover
 27.64 60.85 0.50 2.29 0.63
Asset Turnover
 0.23 0.56 <0.01 0.17 0.07
Working Capital Turnover Ratio
 0.29 0.80 0.01 0.26 0.08
Cash Conversion Cycle
 -1.14K -3.31K -7.10K -1.46K -1.65K
Days of Sales Outstanding
 309.23 11.43 809.14 130.29 481.66
Days of Inventory Outstanding
 0.00 0.00 495.91 151.05 15.28
Days of Payables Outstanding
 1.45K 3.32K 8.40K 1.74K 2.15K
Operating Cycle
 309.23 11.43 1.31K 281.34 496.94
Cash Flow Ratios
Operating Cash Flow Per Share
 -24.91 92.65 -14.01 -7.52 -20.39
Free Cash Flow Per Share
 -25.55 92.18 -14.21 -7.94 -20.65
CapEx Per Share
 0.63 0.47 0.20 0.42 0.25
Free Cash Flow to Operating Cash Flow
 1.03 0.99 1.01 1.06 1.01
Dividend Paid and CapEx Coverage Ratio
 -39.39 195.77 -70.80 -17.92 -80.46
Capital Expenditure Coverage Ratio
 -39.39 195.77 -70.80 -17.92 -80.46
Operating Cash Flow Coverage Ratio
 -4.26 16.10 -2.38 -3.57 -2.12
Operating Cash Flow to Sales Ratio
 -0.38 0.71 -14.85 -1.24 -9.06
Free Cash Flow Yield
-9.30%19.76%-1.99%-2.13%-10.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 7.23 5.09 -44.06 -30.01 -9.64
Price-to-Sales (P/S) Ratio
 4.16 3.57 758.22 61.61 89.48
Price-to-Book (P/B) Ratio
 1.10 2.22 5.52 13.26 11.40
Price-to-Free Cash Flow (P/FCF) Ratio
 -10.75 5.06 -50.36 -46.99 -9.75
Price-to-Operating Cash Flow Ratio
 -11.32 5.03 -51.07 -49.61 -9.88
Price-to-Earnings Growth (PEG) Ratio
 -0.12 >-0.01 -1.44 0.74 0.80
Price-to-Fair Value
 1.10 2.22 5.52 13.26 11.40
Enterprise Value Multiple
 5.95 4.00 -46.67 -31.91 -9.81
Enterprise Value
 15.69B 28.71B 47.45B 20.79B 8.68B
EV to EBITDA
 5.95 4.00 -46.67 -31.91 -9.81
EV to Sales
 3.38 3.12 756.81 60.65 83.46
EV to Free Cash Flow
 -8.73 4.42 -50.26 -46.26 -9.10
EV to Operating Cash Flow
 -8.96 4.40 -50.97 -48.84 -9.21
Tangible Book Value Per Share
 243.94 209.72 129.51 27.93 17.66
Shareholders’ Equity Per Share
 255.87 210.36 129.70 28.15 17.66
Tax and Other Ratios
Effective Tax Rate
 0.03 0.08 <0.01 <0.01 <0.01
Revenue Per Share
 66.01 130.71 0.94 6.06 2.25
Net Income Per Share
 38.94 91.56 -16.24 -12.44 -20.90
Tax Burden
 0.97 0.92 1.00 0.99 0.99
Interest Burden
 1.09 0.98 1.04 1.04 1.06
Research & Development to Revenue
 0.40 0.17 14.67 2.00 5.91
SG&A to Revenue
 0.11 0.03 3.66 0.22 2.64
Stock-Based Compensation to Revenue
 <0.01 0.00 1.39 0.18 0.50
Income Quality
 -0.64 1.01 0.86 0.60 0.78
Currency in DKK